The active substance of the drug "Mildronate" is meldonium (250 mg in the first capsule). The medication belongs to the clinical and pharmacological group of drugs that normalize the metabolism and energy supply of tissues.
Means "Mildronate", the instruction indicates, in its structure is an analog of gamma-butyrobetaine, which is included in every cell of the human body.
Meldonium acts on the tissue tonic, increases physical endurance by providing cells with oxygen, utilization of toxic substances from them. Patients using the drug quickly restore the energy potential of the body.
The medication Mildronate, the use of which is relevant for the treatment of disorders in the cardiovascular system, has been successfully used in therapy to restore blood supply to the brain in order to increase physical and mental performance.
In cases with acute ischemic damage to the myocardium, the use of meldonium can slow down the formation of the necrotic zone and significantly reduce the rehabilitation period for patients.
The drug has the ability to positively affect the contractile function of the myocardium, significantly increase physical endurance, therefore it is used for heart failure. Against the background of taking, the frequency of angina attacks is significantly reduced.
Means "Mildronate", the instruction indicates, is active in the foci of circulatory disorders of the brain, enhancing the movement of blood in the ischemic zone. The drug normalizes the redistribution of blood, increasing its current in the affected area of the brain.
The effectiveness of the use of meldonium for the treatment of fundus pathology associated with changes in blood vessels and dystrophy has been proven.
With the help of the drug, disorders of the nervous system that occur against the background of alcoholism are treated.
Medicine "Mildronate", indications
Meldonium is prescribed:
- with angina pectoris, myocardial infarction;
- with heart failure of a chronic form;
- with dishormonal cardiomyopathy;
- in the treatment of cerebrovascular accidents in complex treatment with other drugs;
- with a decrease in performance;
- with increased physical exertion, athletes;
- in case of withdrawal syndrome against the background of chronic alcoholism in combined treatment with other drugs;
- with hemophthalmia, hemorrhages in the retina;
- with retinal vein thrombosis;
- with diabetic and hypertensive retinopathy.
Means "Mildronate", dosage instructions
The drug has exciting activity, so it is prescribed mainly in the first half of the day.
For the treatment of cardiovascular diseases, meldonium is included in complex therapy with other drugs. The doctor selects a daily dose from 0.5 g to 1 g, divides it, if necessary, into 2 doses per day. The course is designed to last from 4 weeks to 6 weeks.
For the treatment of cardialgia occurring against the background of dishormonal dystrophy of the heart muscle, the doctor prescribes Mildronate capsules, selects a daily dose of 500 mg, and divides it into 2 doses. The course of treatment is designed for 12 days.
The drug "Mildronate", the instruction indicates prescribed for the treatment of cerebrovascular accidents. The doctor chooses 500 mg daily dose in the acute phase of the disease. The medicine is administered per day 1 time intravenously. The course of treatment is designed for 10 days. Then the patient is transferred to oral use of the drug at 0.5 g or 1 g. The course of treatment is designed to last from 4 weeks to 6 weeks.
Chronic circulatory disorders in the brain require the appointment of meldonium in capsules at a dose of 0.5 g to 1 g over a period of time from 4 weeks to 6 weeks. If necessary, the doctor prescribes a second course of treatment in capsules.
For people undergoing mental and physical stress, the specialist prescribes the drug, selects a daily dose of 1,000 mg, and divides it into 4 doses per day of 250 mg. The course of treatment is designed to last from 10 days to 14 days.
Athletes choose a dose of 0.5 g or 1 g 2 times a day if they are undergoing therapy before training. This period in the preparatory phase lasts from 14 to 21 days. The course of use of meldonium during the competition is prescribed for a duration of 10 days to 14 days.
When diagnosed with chronic alcoholism, the doctor prescribes the drug in capsules, selects a daily dose of 2,000 mg, and divides it into 2 doses per day.
The course of treatment is designed to last from 7 to 10 days.
When prescribing the drug, it is important to consider the side effects and contraindications to taking meldonium.